





{"id":828,"date":"2022-08-31T10:45:28","date_gmt":"2022-08-31T08:45:28","guid":{"rendered":"https:\/\/www.degro.org\/ag-stereotaxie\/?page_id=828"},"modified":"2025-02-11T12:21:54","modified_gmt":"2025-02-11T11:21:54","slug":"preop-2-trial","status":"publish","type":"page","link":"https:\/\/www.degro.org\/ag-stereotaxie\/preop-2-trial\/","title":{"rendered":"PREOP-2 Trial"},"content":{"rendered":"<div id=\"pl-828\"  class=\"panel-layout\" ><div id=\"pg-828-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-828-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-828-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2><strong>A multicentre prospective, interventional, randomised trial of PREOPerative radiosurgery compared with postoperative stereotactic radiotherapy for resectable brain metastases (PREOP-2)<\/strong><\/h2>\n<hr \/>\n<p><strong>Main Study PI (Switzerland)<\/strong><br \/>Dr. Dr. Susanne Rogers<br \/>Kantonsspital Aarau, Aarau, Switzerland<br \/><a href=\"mailto:susanne.rogers@ksa.ch\">susanne.rogers@ksa.ch<\/a><\/p>\n<p><strong>Study PI (Germany)<\/strong><br \/>Prof. Dr. med. Michael Synowitz<br \/>University Medical Center Schleswig-Holstein, Campus Kiel<br \/><a href=\"mailto:Michael.Synowitz@uksh.de\">Michael.Synowitz@uksh.de<\/a><\/p>\n<p><strong>Study design:<\/strong><br \/>\u25cf Multi-center, international, randomized, prospective, interventional 2-arm phase III study<\/p>\n<p><strong>Inclusion criteria:<\/strong><br \/>\u25cf Confirmed cancer diagnosis Brain metastasis &lt; 3 other brain metastases for single or multiple fraction radiosurgery No contraindication for MRI<\/p>\n<p><strong>Sample size:<\/strong><br \/>\u25cf160 patients needed, target 200 due to competing risks<\/p>\n<p><strong>Endpoints:<\/strong><br \/>\u25cf Primary endpoint: Incidence of leptomeningeal relapse at 12 months<br \/>\u25cf Secondary endpoint: Overall survival, neurological death, local control, quality of life<br \/>\u25cf Exploratory endpoints: Time to radiosurgery, time to neurosurgery, possible biomarker study<\/p>\n<p><strong>Trial registration<\/strong><\/p>\n<p>NCT05124236 <a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05124236\">https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05124236<\/a><\/p>\n<\/div>\n<\/div><\/div><div id=\"panel-828-0-0-1\" class=\"so-panel widget widget_sow-image\" data-index=\"1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-image so-widget-sow-image-default-8b5b6f678277-828\"\n\t\t\t\n\t\t><h3 class=\"widget-title\">Flowchart<\/h3>\n<div class=\"sow-image-container\">\n\t\t<img \n\tsrc=\"https:\/\/www.degro.org\/ag-stereotaxie\/wp-content\/uploads\/sites\/10\/2022\/08\/Flowshart-PREOP2.png\" width=\"605\" height=\"480\" srcset=\"https:\/\/www.degro.org\/ag-stereotaxie\/wp-content\/uploads\/sites\/10\/2022\/08\/Flowshart-PREOP2.png 605w, https:\/\/www.degro.org\/ag-stereotaxie\/wp-content\/uploads\/sites\/10\/2022\/08\/Flowshart-PREOP2-300x238.png 300w\" sizes=\"(max-width: 605px) 100vw, 605px\" title=\"Flowchart\" alt=\"\" \t\tclass=\"so-widget-image\"\/>\n\t<\/div>\n\n<\/div><\/div><div id=\"panel-828-0-0-2\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"2\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Referenzen<\/strong><\/p>\n<p>Rogers S, Baumert B, Black O, et al. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO). Strahlenther Onkol. 2022; 198(10):919-925. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36006436\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/36006436\/<\/a><\/p>\n<p>Rogers S, Schwyzer L, Lomax N. Preoperative radiosurgery of brain metastases (PREOP-1): A feasibility trial. Clin Transl Radiat Oncol. 2024; 47: 100798.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38938931\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38938931\/<\/a>\u00a0<\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>A multicentre prospective, interventional, randomised trial of PREOPerative radiosurgery compared with postoperative stereotactic radiotherapy for resectable brain metastases (PREOP-2)Main Study PI (Switzerland)Dr. Dr. Susanne RogersKantonsspital Aarau, Aarau, Switzerlandsusanne.rogers@ksa.chStudy PI (Germany)Prof. Dr. med. Michael SynowitzUniversity Medical Center Schleswig-Holstein, Campus KielMichael.Synowitz@uksh.deStudy design:\u25cf &hellip; <\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-828","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/comments?post=828"}],"version-history":[{"count":8,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/828\/revisions"}],"predecessor-version":[{"id":1005,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/828\/revisions\/1005"}],"wp:attachment":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/media?parent=828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}